Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

BACKGROUND: To analyse the discriminative impact of osteopontin (OPN) and activated leukocyte cell adhesion molecule (ALCAM), combined with human epidermal growth factor 2 (HER2) and oestrogen receptor (ER) in breast cancer. METHODS: Osteopontin, ALCAM, HER2 and ER mRNA expression in breast cancer t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ihnen, M, Wirtz, R M, Kalogeras, K T, Milde-Langosch, K, Schmidt, M, Witzel, I, Eleftheraki, A G, Papadimitriou, C, Jänicke, F, Briassoulis, E, Pectasides, D, Rody, A, Fountzilas, G, Müller, V
Format:	Artigo
Language:	Inglês
Published:	Nature Publishing Group 2010
Subjects:	Molecular Diagnostics
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2965857/ https://ncbi.nlm.nih.gov/pubmed/20736952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605840
Tags:	Add Tag No Tags, Be the first to tag this record!

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

Similar Items